Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

RYOIX vs. SHPAX: which is better?

Bottom line

RYOIX vs SHPAX: the short answer

RYOIX (Biotechnology Fund) and SHPAX (Health & Biotechnology Portfolio) are quite different portfolios: only about 23% of their top holdings (by weight) are shared.

But RYOIX is far broader, holding 74 positions to 29 for SHPAX, so beyond the top names it adds exposure SHPAX doesn't have.

RYOIX is cheaper at 1.38% vs 3% — a difference of $162 a year per $10,000 invested.

Over five years, RYOIX returned +4.0% a year vs +3.1% for SHPAX (reporting dates differ).

SHPAX has a front-end sales load of up to 5.75%; the other does not.

Updated Nov 19, 2026

RYOIX vs SHPAX side by side

RYOIXSHPAX
TypeMutual fundMutual fund
Fund familyGuggenheimSaratoga Advantage
CategoryTechnology SectorTechnology Sector
Expense ratio1.38%3%
Annual cost per $10k$138$300
10-yr cost on $10k (prospectus)$1,709$3,702
Max front load—5.75%
12b-1 fee0%—
1-yr return+30.7%−5.5%
5-yr return (annualized)+4.0%+3.1%
10-yr return (annualized)+5.9%+4.1%
Best quarter+28.3%+15.0%
Worst quarter−22.5%−13.0%
Net assets (fund)$136.8M$10.5M
Number of holdings7429
Portfolio turnover75%22%
Returns as ofDec 31, 2025Dec 31, 2024

Source: SEC Form N-PORT and fund prospectuses

Year-by-year returns

YearRYOIXSHPAXDifference
2024−0.7%+0.3%−1.0%
2023+6.1%−0.4%+6.4%
2022−13.1%+2.0%−15.1%
2021+1.8%+16.7%−14.9%
2020+22.1%+3.6%+18.5%
2019+25.0%+16.2%+8.8%
2018−9.0%−5.5%−3.5%
2017+29.7%+12.0%+17.8%
2016−19.5%−2.0%−17.5%

Source: Fund prospectus bar charts

Holdings overlap

6 of RYOIX's top 25 holdings also appear in SHPAX's top 25.

Shared top holdings
HoldingRYOIXSHPAX
Amgen Inc5.05%5.04%
Gilead Sciences Inc4.49%3.94%
Vertex Pharmaceuticals Inc4.32%3.36%
Regeneron Pharmaceuticals Inc2.93%3.93%
United Therapeutics Corp1.72%6.17%
Incyte Corp1.62%2.89%

Source: SEC Form N-PORT

RYOIX top 10

  1. Abbvie Inc — 8.17%
  2. Amgen Inc — 5.05%
  3. Gilead Sciences Inc — 4.49%
  4. Vertex Pharmaceuticals Inc — 4.32%
  5. Regeneron Pharmaceuticals Inc — 2.93%
  6. Revolution Medicines Inc — 2.48%
  7. Alnylam Pharmaceuticals Inc — 2.36%
  8. Beone Medicines Ltd — 2.17%
  9. Moderna Inc — 2.15%
  10. Biogen Inc — 2.13%

SHPAX top 10

  1. Cardinal Health Inc — 6.44%
  2. Jazz Pharmaceuticals Plc — 6.19%
  3. United Therapeutics Corp — 6.17%
  4. Amgen Inc — 5.04%
  5. Mckesson Corp — 4.90%
  6. Lantheus Holdings Inc — 4.64%
  7. Exelixis Inc — 4.55%
  8. Novartis Ag — 4.50%
  9. Cencora Inc — 4.33%
  10. Gilead Sciences Inc — 3.94%

FAQ

What is the difference between RYOIX and SHPAX?
RYOIX (Biotechnology Fund) and SHPAX (Health & Biotechnology Portfolio) are quite different portfolios: only about 23% of their top holdings (by weight) are shared. But RYOIX is far broader, holding 74 positions to 29 for SHPAX, so beyond the top names it adds exposure SHPAX doesn't have.
Which is cheaper, RYOIX or SHPAX?
RYOIX has the lower expense ratio (1.38%).
Should I own both RYOIX and SHPAX?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.

Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.